Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
ICD-9-CM/ICD-10-CM Crosswalk for Adult Male Reproductive Disorders 2015 ICD-9-CM 253.4 Other anterior pituitary disorders (isolated or partial deficiency of an anterior pituitary hormone, other than growth hormone) 253.7 Hypopituitarism, iatrogenic--also code cause (use additional E code to identify cause) 257.0 Testicular hyperfunction (hypersecretion of testicular hormones) 257.1 Postablative testicular hypofunction Testicular hypofunction: iatrogenic, postirradiation, postsurgical 257.2 Other testicular hypofunction (defective synthesis of testicular androgen, eunuchoidism [NOS, hypogonadotropic], failure [Leydig’s cells, adult; seminiferous tubule, adult], testicular hypogonadism 257.8 Other testicular dysfunction 257.9 Unspecified testicular dysfunction 259.5 Androgen insensitivity syndrome (aka testicular feminization) 275.0 Disorders of iron metabolism (e.g. Hemochromatosis) 289.0 Polycythemia, secondary 302.50 Trans-sexualism, unspecified sexual history 302.72 Psychosexual dysfunction with ICD-10-CM E23.0 Hypopituitarism (Hypogonadotropic hypogonadism, Isolated deficiency of gonadotropin, Kallmann’s syndrome) E23.1 Drug-induced hypopituitarism E89.3 Postprocedural hypopituitarism E29.0 Testicular hyperfunction (hypersecretion of testicular hormones) E89.5 Postprocedural testicular hypofunction E29.1 Testicular hypofunction (defective synthesis of testicular androgen NOS, 5delta-reductase deficiency [with male pseudohermaphroditism], testicular hypogonadism NOS) Use additional code for adverse effect, if applicable, to identify drug (T36-T50 with 5th or 6th character 5) E29.8 Other testicular dysfunction E29.9 Testicular dysfunction, unspecified E34.50 Androgen insensitivity syndrome, unspecified E34.51 Complete androgen insensitivity syndrome E34.52 Partial androgen insensitivity syndrome E83.110 Hereditary hemochromatosis E83.111 Hemochromatosis due to repeated blood cell transfusions E83.118 Other hemochromatosis E83.119 Hemochromatosis, unspecified E83.19 Other disorders of iron metabolism D75.1 Secondary polycythemia F64.1 Gender identity disorder in adolescence and adulthood Z87.890 Personal history of sex reassignment F52.21 Male erectile disorder (psychogenic All information is subject to change. This is not an all-inclusive list. inhibited sexual excitement (aka non-organic or psychogenic erectile dysfunction) 302.74 Male orgasmic disorder 302.75 Premature ejaculation 456.4 Scrotal varices (varicocele) 600.00 Hypertrophy (benign) of prostate w/o urinary obstruction and other lower urinary tract symptoms (LUTS) 600.01 Hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (LUTS) 600.10 Nodular prostate (hard, firm prostate; multinodular prostate) without urinary obstruction ( 600.11 Nodular prostate with urinary obstruction 601.0 Prostatitis, acute 601.1 Chronic prostatitis 601.9 Prostatitis unspecified 603.9 Hydrocele, unspecified 604.90 Orchitis and epididymitis, unspecified impotence) F52.32 Male orgasmic disorder F52.4 Premature ejaculation I86.1 Scrotal varices (varicocele) N40.0 Enlarged prostate w/o lower urinary tract symptoms (enlarged prostate NOS, enlarged prostate w/o LUTS) N40.1 Enlarged prostate with lower urinary tract symptoms (enlarged prostate with LUTS) Use additional code for associated symptoms, when specified: incomplete bladder emptying [R39.14], nocturia [R35.1], straining on urination [R39.16], urinary frequency [R35.0], urinary hesitancy [R39.11], urinary incontinence [N39.4-], urinary obstruction [N13.8], urinary retention [R33.8], urinary urgency [R39.15], weak urinary stream [R39.12] N40.2 Nodular prostate without lower urinary tract symptoms (nodular prostate without LUTS) N40.3 Nodular prostate with lower urinary tract symptoms Use additional code for associated symptoms, when specified: incomplete bladder emptying [R39.14], nocturia [R35.1], straining on urination [R39.16], urinary frequency [R35.0], urinary hesitancy [R39.11], urinary incontinence [N39.4-], urinary obstruction [N13.8], urinary retention [R33.8], urinary urgency [R39.15], weak urinary stream [R39.12] N41.0 Acute prostatitis N41.1 Chronic prostatitis N41.9 Inflammatory disease of prostate, unspecified (prostatitis NOS) N43.0 Encysted hydrocele N43.1 Infected hydrocele N43.2 Other hydrocele N43.3 Hydrocele, unspecified N45.1 Epididymitis All information is subject to change. This is not an all-inclusive list. 606.0 Infertility, male: Azoospermia 606.1 Infertility, male: Oligospermia 606.8 Infertility due to extratesticular causes N/A 606.9 Infertility, male, unspecified 607.3 Priapism 607.84 Impotence, organic origin (physiologic, not psychogenic) N45.2 Orchitis N45.3 Epididymo-orchitis N46.01 Organic azoospermia N46.021 Azoospermia due to drug therapy N46.022 Azoospermia due to infection N46.023 Azoospermia due to obstruction of efferent ducts N46.024 Azoospermia due to radiation N46.025 Azoospermia due to systemic disease N46.029 Azoospermia due to other extratesticular causes N46.11 Organic oligospermia N46.121 Oligospermia due to drug therapy N46.122 Oligospermia due to infection N46.123 Oligospermia due to obstruction of efferent ducts N46.124 Oligospermia due to radiation N46.125 Oligospermia due to systemic disease N46.129 Oligospermia due to other extratesticular causes N46.8 Other male infertility N46.9 Male infertility, unspecified N48.30 Priapism, unspecified N48.31 Priapism due to trauma N48.32 Priapism due to disease classified elsewhere N48.33 Priapism, drug-induced N48.39 Other priapism N52.01 Erectile dysfunction due to arterial insufficiency N52.02 Corporo-venous occlusive erectile dysfunction N52.03 Combined arterial insufficiency and corporo-venous occlusive erectile dysfunction N52.1 Erectile dysfunction due to diseases classified elsewhere N52.2 Drug-induced erectile dysfunction N52.31 Erectile dysfunction following radical prostatectomy N52.32 Erectile dysfunction following radical All information is subject to change. This is not an all-inclusive list. 607.85 Peyronie’s disease 608.1 Spermatocele 608.3 Atrophy of testis 608.86 Edema of male genital organs (testicular swelling, mass, or lump) cystectomy N52.33 Erectile dysfunction following urethral surgery N52.34 Erectile dysfunction following simple prostatectomy N52.39 Other post-surgical erectile dysfunction N52.8 Other male erectile dysfunction N52.9 Male erectile dysfunction, unspecified N48.6 Induration penis plastica (Peyronie’s disease, plastic induration of penis) N43.40 Spermatocele of epididymis, unspecified N43.41 Spermatocele of epididymis, single N43.42 Spermatocele of epididymis, multiple N50.0 Atrophy of testis N50.8 Other specified disorders of male genital organs (edema/hypertrophy of scrotum, seminal vesicles, spermatic cord, testis, tunica vaginalis, and vas deferens, OR 608.87 Retrograde ejaculation 608.89 Other specified disorders of male genital organs 608.9 Unspecified disorder of male genital organs 611.1 Gynecomastia 611.6 Galactorrhea not associated with childbirth 611.71 Mastodynia (pain in breast) 611.72 Lump or mass in breast 611.79 Other disorders of breast (nipple discharge) 752.51 Testis, undescended (cryptorchidism) R22.9 Localized swelling, mass, and lump, unspecified N53.14 Retrograde ejaculation N50.3 Cyst of epididymis N50.9 Disorder of male genital organs, unspecified N62 Hypertrophy of breast N64.3 Galactorrhea not associated with childbirth N64.4 Mastodynia N63 Unspecified lump in breast N64.52 Nipple discharge Q53.00 Ectopic testis, unspecified Q53.01 Ectopic testis, unilateral Q53.02 Ectopic testes, bilateral Q53.10 Unspecified undescended testicle, unilateral Q53.11 Abdominal testis, unilateral All information is subject to change. This is not an all-inclusive list. 752.64 Micropenis 758.7 Klinefelter’s syndrome 780.57 Sleep apnea, unspecified 780.79 Fatigue & malaise, other 780.8 Hyperhidrosis, generalized (diaphoresis, excessive sweating) 781.1 Disturbances of sensation of smell and taste (anosmia) 782.62 Flushing 788.41 Urinary frequency 788.43 Nocturia 788.61 Splitting of urinary stream (intermittent urinary stream) 788.62 Slowing of urinary stream (weak stream) 788.63 Urgency of urination 788.64 Urinary hesitancy 788.65 Straining on urination 788.69 Other abnormality of urination 790.93 Elevated prostate specific antigen (PSA) 792.2 Nonspecific abnormal findings in other body substances: semen (abnormal spermatozoa) Q53.12 Ectopic perineal testis, unilateral Q53.20 Undescended testicle, unspecified, bilateral Q53.21 Abdominal testis, bilateral Q53.22 Ectopic perineal testis, bilateral Q53.9 Undescended testicle, unspecified Q55.62 Hypoplasia of penis Q98.0 Klinefelter syndrome karyotype 47, XXY Q98.1 Klinefelter syndrome, male with more than two X chromosomes Q98.3 Other male with 46, XX karyotype Q98.4 Klinefelter syndrome, unspecified G47.30 Sleep apnea, unspecified G93.3 Postviral fatigue syndrome R53.0 Neoplastic (malignant) related fatigue R53.1 Weakness R53.81 Other malaise R53.83 Other fatigue R61 Generalized hyperhidrosis (excessive sweating, night sweats) R43.0 Anosmia R23.2 Flushing R35.0 Frequency of micturition R35.1 Nocturia R39.13 Splitting of urinary stream (intermittent) R39.12 Poor urinary stream (weak urinary stream) R39.15 Urgency of urination R39.11 Hesitancy of micturition R39.16 Straining to void R39.14 Feeling of incomplete bladder emptying R39.19 Other difficulties with micturition R97.2 Elevated prostate specific antigen (PSA) R86.0 Abnormal levels of enzymes in specimens from male genital organs R86.1 Abnormal levels of hormones in specimens from male genital organs R86.2 Abnormal level of other drugs, All information is subject to change. This is not an all-inclusive list. 799.22 Irritability 799.24 Emotional lability 799.81 Decreased sexual desire NOS N/A 962.1 Poisoning by hormones and synthetic substitutes: androgens and anabolic congeners medicaments and biological substances in specimens from male genital organs R86.3 Abnormal levels of substances chiefly nonmedicinal as to source in specimens from male genital organs R86.4 Abnormal immunological findings in specimens from male genital organs R86.5 Abnormal microbiological findings in specimens from male genital organs R86.6 Abnormal cytological findings in specimens from male genital organs R86.7 Abnormal histological findings in specimens from male genital organs R86.8 Other abnormal findings in specimens from male genital organs (abnormal chromosomal findings in specimens from male genital organs) R86.9 Unspecified abnormal finding in specimens from male genital organs R45.4 Irritability and anger R45.86 Emotional lability R68.62 Decreased libido T38.6X1X Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, accidental (unintentional) (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.6X2X Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.6X3X Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, assault (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.6X4X Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, undetermined (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.7X1X Poisoning by androgens and anabolic congeners, accidental (unintentional) (X depends on initial (A), All information is subject to change. This is not an all-inclusive list. 962.4 Poisoning by hormones and synthetic substitutes: anterior pituitary hormones (corticotropin, gonadotropin, somatotropin [growth hormone]) E932.0 Adverse effects of adrenal cortical steroids N/A E932.1 Adverse effects of androgens and anabolic congeners E932.4 Adverse effects of anterior pituitary hormones (corticotropin, gonadotropin, somatotropin [growth hormone]) subsequent (D), or sequela (S) encounter) T38.7X2X Poisoning by androgens and anabolic congeners, intentional self-harm (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.7X3X Poisoning by androgens and anabolic congeners, assault (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.7X4X Poisoning by androgens and anabolic congeners, undetermined (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.811X Poisoning by anterior pituitary hormones (unintentional) (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.812X Poisoning by anterior pituitary hormones, intentional self-harm (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.813X Poisoning by anterior pituitary hormones, assault (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.814X Poisoning by anterior pituitary hormones, undetermined (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.0X5X Adverse effect of glucocorticoids and synthetic analogues (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.6X5X Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, undetermined (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.7X5X Adverse effect of androgens and anabolic congeners (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.815X Adverse effect of anterior pituitary [adenohypophyseal] hormones (X depends on initial (A), subsequent (D), or sequela (S) encounter) All information is subject to change. This is not an all-inclusive list. E935.2 Adverse effects of other opiates and related narcotics (codeine, morphine, opium [alkaloids], meperidine [pethidine]) N/A N/A N/A V07.51 Long-term (current) drug use: selective estrogen receptor modulators (SERMs) V10.3 Personal history of malignant neoplasm of breast Personal history of malignant neoplasm of male genital organ: V10.45 Unspecified V10. 46 Prostate V10.47 Testis V10.48 Epididymis V10.49 Other male genital organs V12.29 Personal history of other endocrine, metabolic and immunity disorders V12.51 Personal history of diseases of circulatory system: venous thrombosis and T40.0X5X Adverse effect of opium (X depends on initial (A), subsequent (D), or sequela (S) encounter) T40.2X5X Adverse effect of other opioids (X depends on initial (A), subsequent (D), or sequela (S) encounter) T40.4X5X Adverse effect of other synthetic narcotics (X depends on initial (A), subsequent (D), or sequela (S) encounter) T40.605X Adverse effect of unspecified narcotics (X depends on initial (A), subsequent (D), or sequela (S) encounter) T40.695X Adverse effect of other narcotics (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.6X6X Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.7X6X Underdosing of androgens and anabolic congeners (X depends on initial (A), subsequent (D), or sequela (S) encounter) T38.816X Underdosing of anterior pituitary [adenohypophyseal] hormones (X depends on initial (A), subsequent (D), or sequela (S) encounter) Z79.810 Long-term (current) use of selective estrogen receptor modulators (SERMs) Z85.3 Personal history of malignant neoplasm of breast Personal history of malignant neoplasm of male genital organ: Z85.45 Unspecified Z85.46 Prostate Z85.47 Testis Z85.48 Epididymis Z85.49 Other male genital organs Z86.39 Personal history of other endocrine nutritional and metabolic diseases Z86.718 Personal history of other venous thrombosis and embolism All information is subject to change. This is not an all-inclusive list. embolism Family history of malignant neoplasm of genital organs: V16.40 Genital organs, unspecified V16.42 Prostate V16.43 Testis V16.59 Other V16.8 Family history of malignant neoplasm of male breast V18.19 Family history of other endocrine and metabolic disorders V25.2 Encounter for contraceptive management: sterilization (admission for interruption of vas deferens) V25.8 Encounter for contraceptive management: other specified contraceptive management (postvasectomy sperm count) Procreative management: V26.0 Vasoplasty after previous sterilization Procreative management - Investigation and testing: V26.21 Fertility testing (sperm count) V26.22 Aftercare following sterilization reversal (sperm count following sterilization reversal) Procreative management - Genetic counseling and testing: V26.34 Testing of male for genetic disease carrier status V26.35 Testing of male partner of female with recurrent pregnancy loss V26.39 Other genetic testing of male V26.33 Genetic counseling Procreative management - General counseling and advice: V26.41 Procreative counseling and advice using natural family planning V26.42 Encounter for fertility preservation Family history of malignant neoplasm of genital organs: N/A Z80.42 Prostate Z80.43 Testis Z80.49 Other genital organs Z80.8 Family history of malignant neoplasm or other organs or systems OR Z80.3 Family history of malignant neoplasm of breast Z83.49 Family history of other endocrine and metabolic disorders Z30.2 Encounter for contraceptive management: sterilization Z30.8 Encounter for other contraceptive management: postvasectomy sperm count Encounter for procreative management: Z31.0 Reversal of previous sterilization Encounter for procreative management Procreative investigation and testing: Z31.41 Fertility testing (sperm count) Z31.42 Aftercare following sterilization reversal (sperm count following sterilization reversal) Encounter for genetic testing of male for procreative management: Z31.440 Encounter of male for testing for genetic disease carrier status for procreative management Z31.441 Encounter for testing of male partner patient with recurrent pregnancy loss Z31.448 Encounter for other genetic testing of male for procreative management Z31.5 Encounter for genetic counseling Encounter for general counseling and advice on procreation: Z31.61 Procreative counseling and advice using natural family planning Z31.62 Encounter for fertility preservation All information is subject to change. This is not an all-inclusive list. counseling (prior to cancer therapy, prior surgical removal of gonads) V26.49 Other procreative management counseling and advice Procreative management – sterilization status: V26.52 Vasectomy Procreative management – Other specified procreative management V26.82 Encounter for fertility preservation procedure (prior to cancer therapy, prior to surgical removal of gonads) V26.89 Other specified procreative management V58.65 Long-term (current) use of steroids V58.69 Long-term (current) use of other medications: methadone for pain control, opiate analgesics, other high-risk medications) V76.44 Special screening for malignant neoplasm: prostate V76.45 Special screening for malignant neoplasm: testis V77.99 Other & unspecified screening for nutritional, metabolic, and immunity disorders V84.03 Genetic susceptibility to malignant neoplasm of prostate N/A N/A N/A counseling (prior to cancer therapy, prior to surgical removal of gonads) Z31.69 Other general counseling and advice on procreation Other postprocedural states – sterilization status: Z98.52 Vasectomy Encounter for other procreative management: Z31.84 Encounter for fertility preservation procedure (prior to cancer therapy, prior to surgical removal of gonads) Z31.89 Encounter for other procreative management Z79.51 Long-term (current) use of inhaled steroids Z79.52 Long-term (current) use of systemic steroids Z79.891 Long-term (current) use of opiate analgesic Z12.5 Encounter for screening for malignant neoplasm of prostate Z12.71 Encounter for screening for malignant neoplasm of testis Z13.29 Encounter for screening other suspected endocrine disorder Z15.03 Genetic susceptibility to malignant neoplasm of prostate Z91.120 Patient’s intentional underdosing of medication regimen due to financial hardship (code first underdosing of medication [T36T50] with fifth or sixth character of 6) Z91.128 Patient’s intentional underdosing of medication regimen for other reason (code first underdosing of medication [T36-T50] with fifth or sixth character of 6) Z91.130 Patient’s unintentional underdosing of medication regimen due to age-related debility (code first underdosing of medication [T36-T50] with fifth or sixth character of 6) All information is subject to change. This is not an all-inclusive list. N/A N/A N/A Z91.138 Patient’s unintentional underdosing of medication regimen for other reason (code first underdosing of medication [T36T50] with fifth or sixth character of 6) Z91.14 Patient’s other noncompliance with medication regimen (patient’s underdosing of medication NOS) (code first underdosing of medication [T36-T50] with fifth or sixth character of 6) Z91.19 Patient’s noncompliance with other medical treatment and regimen All information is subject to change. This is not an all-inclusive list.